Cocrystal Pharma (COCP) Tax Provisions (2010 - 2018)

Cocrystal Pharma (COCP) has 5 years of Tax Provisions data on file, last reported at -$12.1 million in Q4 2018.

• For the quarter ending Q4 2018, Tax Provisions fell 276.21% year-over-year to -$12.1 million; the trailing twelve-month figure through Dec 2018 stood at -$13.6 million (down 126.28% YoY), and the FY2018 full-year result was -$13.6 million, down 97.41% from the prior year.
• Tax Provisions slipped to -$12.1 million in Q4 2018, from -$483000.0 in the prior quarter.
• In the past five years, Tax Provisions ranged from a high of $29.4 million in Q4 2016 to a low of -$12.1 million in Q4 2018.
• A 4-year average of $4.2 million and a median of -$52000.0 in 2015 frame the typical range for Tax Provisions.
• Across the five-year window, Tax Provisions jumped 92.12% in 2016 and tumbled 276.21% in 2018, its largest moves.
• Tracing COCP's Tax Provisions over 4 years: stood at $15.3 million in 2015, then jumped by 92.12% to $29.4 million in 2016, then tumbled by 76.59% to $6.9 million in 2017, then plunged by 276.21% to -$12.1 million in 2018.
• Business Quant data shows COCP's Tax Provisions at -$12.1 million in Q4 2018, -$483000.0 in Q3 2018, and -$554000.0 in Q2 2018.